Health

  • January 02, 2026

    SnapChat, Pork And Big Prosecutions: Trials To Watch In 2026

    The coming year is set to bring high-profile trials, including in the criminal case against SCOTUSblog co-founder Tom Goldstein, as well as bellwether trials in multidistrict litigation concerning social media's effects on mental health and allegations of price-fixing in the generic-drug industry.

  • January 02, 2026

    Pennsylvania Cases To Watch In 2026

    As winter's chill rings in the new year, several high-profile cases are set to heat up Pennsylvania's dockets in 2026, including disciplinary charges against a judge associated with rapper Meek Mill, a pending appeals decision on the lawfulness of semiautomatic rifles, and Philadelphia's quest to hold pharmacy benefit managers accountable for the opioid epidemic.

  • January 02, 2026

    5 White Collar Enforcement Trends To Watch In 2026

    Shifts in white collar enforcement priorities during President Donald Trump's second term in office will pave the way for more changes in the year ahead, as experts predict a ramping up of enforcement actions related to everything from healthcare fraud and tariff evasion to cartels and artificial intelligence.

  • January 02, 2026

    Pennsylvania Legislation To Watch In 2026

    After belatedly passing a budget for the rest of the fiscal year, Pennsylvania's General Assembly is turning its focus to proposals that would expand liability for data breaches and create a new method for designing voter maps.

  • January 02, 2026

    Milbank PE Co-Head On What Will Drive Deals In 2026

    With private equity players hoping for a more active 2026, attorneys are increasingly helping sponsors navigate AI-related diligence, defense sector dealmaking and ongoing liquidity pressure in a market where geopolitical uncertainty and valuation gaps still complicate traditional exits.

  • January 02, 2026

    The High-Stakes Healthcare AI Battles To Watch In 2026

    Courts across the country are set to hear a wave of litigation in the coming year that will begin to draw the legal boundaries around artificial intelligence in healthcare and the life sciences. Law360 spoke with legal experts about the high-stakes AI litigation set to unfold in 2026.

  • January 01, 2026

    Blue Slip Fight Looms Over Trump's 2026 Judicial Outlook

    In 2025, President Donald Trump put 20 district and six circuit judges on the federal bench. In the year ahead, a fight over home state senators' ability to block district court picks could make it more difficult for him to match that record.

  • January 01, 2026

    4 High Court Cases To Watch This Spring

    The U.S. Supreme Court justices will return from the winter holidays to tackle several constitutional disputes that range from who is entitled to birthright citizenship to whether transgender individuals are entitled to heightened levels of protection from discrimination. 

  • January 01, 2026

    BigLaw Leaders Tackle Growth, AI, Remote Work In New Year

    Rapid business growth, cultural changes caused by remote work and generative AI are creating challenges and opportunities for law firm leaders going into the New Year. Here, seven top firm leaders share what’s running through their minds as they lie awake at night.

  • December 23, 2025

    Trump Admin Beats Chamber Suit Over $100K H-1B Visa Fee

    A Washington, D.C., federal judge on Tuesday refused to block the Trump administration's new $100,000 H-1B visa fee, ruling in the U.S. Chamber of Commerce's lawsuit challenging the fee that President Donald Trump has "broad authority" to restrict noncitizens' entry.

  • December 23, 2025

    Top Illinois Decisions Of 2025

    State and federal courts have handed down rulings in Illinois cases this year that made clear plaintiffs must allege concrete injury for common law standing, narrowed the scope of the federal anti-kickback statute and laid out a new standard for certifying collective actions.

  • December 23, 2025

    Philly Joins MDL Against Drug Cos., PBMs Over Insulin Prices

    Philadelphia on Tuesday sued drug manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with several pharmacy benefit managers, joining multidistrict litigation in New Jersey federal court accusing the companies of illegally inflating the price of insulin.

  • December 23, 2025

    Full 9th Circ. Won't Hear Ex-Theranos Exec Balwani's Appeal

    A Ninth Circuit panel rejected ex-Theranos executive Ramesh "Sunny" Balwani's en banc hearing request to reconsider his 12-count conviction and nearly 13-year prison sentence, while also amending its opinion to clarify that there was "ample evidence" to convict Balwani, even if prosecutors failed to correct a witness's testimony.

  • December 23, 2025

    Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'

    Amarin Pharma Inc. on Tuesday urged the U.S. Supreme Court to reject the U.S. solicitor general's call to hear a patent case involving generic drug "skinny labels," saying the dispute over the company's heart drug Vascepa deals with factual issues not suitable for high court review.

  • December 23, 2025

    AdaptHealth To Pay Investors $35M To End Inflated-Sales Suit

    Medical device provider AdaptHealth Corp. has agreed to pay $35 million to settle a lawsuit accusing it of deceiving shareholders about its revenue projections as it "routinely engaged in improper and unethical tactics to inflate sales numbers." 

  • December 23, 2025

    Squires Will Review If Hydrafacial's ITC Win Should End IPR

    U.S. Patent and Trademark Office Director John Squires has paused the Patent Trial and Appeal Board's review of a Hydrafacial LLC skin treatment patent to consider the effect of a related U.S. International Trade Commission decision.

  • December 23, 2025

    Top North Carolina Cases Of 2025

    A sweep of settlements in major lawsuits punctuated the second half of the year in North Carolina, from a record-breaking wrongful death deal to an eleventh-hour resolution in a lending fight over a biogas development project. Here are some of the top North Carolina case outcomes in the second half of 2025.

  • December 23, 2025

    'Surprise' Expert Prompts Axing Of $14M Car Crash Verdict

    A California appellate court has vacated a $13.8 million jury verdict after finding that the trial court abused its discretion by allowing a "surprise" medical expert witness to testify at an auto collision trial, saying his testimony likely affected the jury's substantial award.

  • December 23, 2025

    Connecticut's Most Notable Cases Of 2025

    Two attorneys who were licensed in Connecticut were convicted in 2025 on charges that either did or could result in prison time, including a longtime real estate attorney who fatally shot a man in his law firm's parking lot. And the state's largest healthcare system said it would pay $45 million to exit an agreement to buy three ailing hospitals that were in much worse condition than previously known. Here's a look back at three of the top cases of 2025.

  • December 23, 2025

    DHS Finalizes Rule Shifting H-1B Odds To Higher Earners

    The Trump administration finalized changes to the H-1B lottery Tuesday, unveiling a final rule it said will favor higher-paid and higher-skilled positions and tamp down on employers exploiting the program to hire low-wage workers and depress the wages of U.S. workers.

  • December 23, 2025

    Blue Cross Seeks McDonald Hopkins' Fraud Warning Docs

    Advice that McDonald Hopkins LLC gave a Florida hospital manager about potential exposure to criminal prosecution for healthcare fraud is neither privileged nor work product, and so should be handed over to a Blue Cross health insurer being sued for malicious prosecution in Georgia federal court, the insurer said.

  • December 23, 2025

    Sanofi Eczema Drug Linked To Lymphoma, Suit Says

    Drug manufacturers Regeneron Pharmaceuticals and Sanofi were hit with a lawsuit Monday from a Georgia woman alleging the companies have covered up a "strong and consistent causal relationship" between their drug Dupixent and a form of non-Hodgkins lymphoma.

  • December 23, 2025

    Patients Say Pa. Med Mal Firm Left Data Vulnerable To Hackers

    A Pittsburgh law firm that handles medical malpractice and insurance litigation faces a proposed class action complaint alleging that it failed to protect the private health and personal data of patients whose information was stolen in a data breach.

  • December 23, 2025

    11th Circ. Asked To Rehear Pregnancy Center Vandalism Case

    A Florida woman convicted of vandalizing crisis pregnancy centers across the state asked the Eleventh Circuit Monday to reconsider a ruling affirming her conviction, arguing that she should not have been prosecuted under a conspiracy statute for violating the Freedom of Access to Clinic Entrances Act.

  • December 23, 2025

    Johnson & Johnson Hit With $1.5B Talc Verdict In Baltimore

    A Baltimore jury late Monday returned a walloping verdict of more than $1.5 billion in favor of a woman who claimed that Johnson & Johnson talc products caused her mesothelioma, which her attorneys say is the largest verdict against the company for a single plaintiff.

Expert Analysis

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

  • Litigation Funding Could Create Ethics Issues For Attorneys

    Author Photo

    A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.

  • E-Discovery Quarterly: Recent Rulings On Dynamic Databases

    Author Photo

    Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.

  • Prison Body Cams Raise Health Privacy Compliance Issues

    Author Photo

    The increasing use of prison staff body cameras to enhance transparency and safety presents correctional healthcare partners with new risk management questions where they must carefully reconcile the benefits of surveillance with the imperative to protect patient privacy, say attorneys at Gordon Rees.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

  • Employer Considerations After 11th Circ. Gender Care Ruling

    Author Photo

    The Eleventh Circuit's en banc decision in Lange v. Houston County, Georgia, finding that a health plan did not violate Title VII by excluding coverage for gender-affirming care, shows that plans must be increasingly cognizant of federal and state liability as states pass varying mandates, say attorneys at Miller & Chevalier.

  • Series

    The Biz Court Digest: How It Works In Massachusetts

    Author Photo

    Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.

  • How Healthcare Practices Can Prepare For ICE Visits

    Author Photo

    Healthcare providers that may face encounters with immigration enforcement should familiarize themselves with compliance obligations beyond ensuring employment authorization, and mitigate risk by establishing clear policies and specific procedures that safeguard patient rights and manage staff interactions with agents, say attorneys at Roetzel & Andress.

  • Adapting To Calif.'s Enhanced Regulation Of PE In Healthcare

    Author Photo

    New California legislation enhances oversight on the role of private equity groups and hedge funds in healthcare transactions, featuring both a highly targeted nature and vague language that will require organizations to carefully evaluate existing practices, says Andrew Demetriou at Husch Blackwell.

  • Why Appellees Should Write Their Answering Brief First

    Author Photo

    Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.

  • Navigating DEA Quotas: Key To Psychedelics Industry Growth

    Author Photo

    As new compounds like DOI enter the Schedule I landscape, manufacturers who anticipate U.S. Drug Enforcement Administration quota regulations, and build quota management into their broader strategy, will be best equipped to meet the growing demand, say Kimberly Chew at Husch Blackwell and Jaime Dwight at Promega.

  • Federal Acquisition Rules Get Measured Makeover

    Author Photo

    The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.